# Linda Sciuto

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/linda-sciuto/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,687 |
| Field | Lung Cancer Research Studies |
| h-index | 16 |
| i10-index | 17 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5008933680 |
| ORCID iD | 0000-0001-6314-8991 |
| Works | 175 |

## Researcher papers

- [Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy](https://scholariq.org/papers/eighteen-year-results-in-the-treatment-of-early-breast-carcinoma-with-mastectomy/)
- [Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress](https://scholariq.org/papers/therapeutic-targeting-of-atr-yields-durable-regressions-in-small-cell-lung/)
- [Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors](https://scholariq.org/papers/phase-i-study-of-atr-inhibitor-m6620-in-combination-with-topotecan-in-patients/)
- [Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes](https://scholariq.org/papers/extrachromosomal-dna-amplification-contributes-to-small-cell-lung-cancer/)
- [Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models](https://scholariq.org/papers/heterogeneity-of-neuroendocrine-transcriptional-states-in-metastatic-small-cell/)
- [Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies](https://scholariq.org/papers/whole-exome-sequencing-reveals-germline-mutated-small-cell-lung-cancer-subtype/)
- [Twenty-five year results of the national cancer institute randomized breast conservation trial](https://scholariq.org/papers/twenty-five-year-results-of-the-national-cancer-institute-randomized-breast/)
- [Intrarectal Amifostine During External Beam Radiation Therapy for Prostate Cancer Produces Significant Improvements in Quality of Life Measured by EPIC Score](https://scholariq.org/papers/intrarectal-amifostine-during-external-beam-radiation-therapy-for-prostate/)
- [Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer](https://scholariq.org/papers/berzosertib-plus-topotecan-vs-topotecan-alone-in-patients-with-relapsed-small/)
- [Long-Term Outcomes and Toxicity of Concurrent Paclitaxel and Radiotherapy for Locally Advanced Head-and-Neck Cancer](https://scholariq.org/papers/long-term-outcomes-and-toxicity-of-concurrent-paclitaxel-and-radiotherapy-for/)
- [Targeting genomic instability in extrapulmonary small cell neuroendocrine cancers: A phase II study with ATR inhibitor berzosertib and topotecan.](https://scholariq.org/papers/targeting-genomic-instability-in-extrapulmonary-small-cell-neuroendocrine/)

## Researcher topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.